- This event has passed.
SynBioBeta 2026: The Global Synthetic Biology Partnering Summit
Every May for the past 14 years, more than 2,000 investors, Fortune 500 executives, founders, and scientists have gathered at SynBioBeta to make deals, start partnerships, and shape what the next 6–12 months of the life sciences ecosystem will look like.
This year’s program spans 6 frontier areas shaping the future of biology:
AI × Biology
Foundation models, multimodal biological AI, predictive design for drugs, materials, and sustainable systems.
Human Health & Longevity
AI-powered drug discovery, cell and gene therapies, diagnostics, and engineered therapeutics.
Planetary Health & Sustainability
Food and agriculture, climate tech, sustainable materials, and bio-enabled manufacturing.
Biomanufacturing at Scale
Continuous fermentation, scalable bioprocessing, and real-time monitoring for cost-competitive production.
Tools, Tech & Platforms
Sequencing, synthesis, genome editing, automation, cloud labs, and AI-driven discovery platforms.
The Business of Biology
Commercialization, market strategy, funding, partnerships, regulatory, and IP strategy.
The stage will feature leaders such as David Sinclair, Pardis Sabeti, Drew Endy, and Emily Leproust, alongside executives and research leaders from organizations including:
DARPA • ARPA-H • U.S. Department of Energy
Industry leaders including:
Procter & Gamble • Unilever • Mars
And global biopharma companies including:
AstraZeneca • GlaxoSmithKline • Novo Nordisk • Eli Lilly
CLS members receive a 10% discount to attend the full conference. Contact your account manager or reach out to [email protected] for more information.
Hosted by:
